Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Current assets:    
Cash and cash equivalents $ 3,544 $ 3,820
Accounts receivable, net 2,439 2,572
Inventories, net 2,730 2,858
Prepaid expenses and other current assets 4,621 4,308
Current portion of deferred consideration, net of discount 253 240
Total current assets 13,587 13,798
Property and equipment, net 485 488
Operating lease, right of use assets 354 418
Deferred tax asset 908 949
Deferred consideration, net of discount, less current portion 482 505
Other assets 77 73
Total assets 15,893 16,231
Current liabilities:    
Accounts payable 1,090 841
Accrued expenses and other current liabilities 2,255 2,029
Deferred revenue 100 100
Deferred revenue Invekra 62 60
Short-term debt 301 431
Operating lease liabilities 233 256
Total current liabilities 4,041 3,717
Long-term deferred revenue Invekra 132 140
Withholding tax payable 4,357 4,235
Operating lease liabilities, less current portion 121 162
Total liabilities 8,651 8,254
Commitments and Contingencies (Note 5)
Stockholders’ Equity    
Convertible preferred stock, $0.0001 par value; 714,286 shares authorized at June 30, 2023 and March 31, 2023, respectively, no shares issued and outstanding at June 30, 2023 and March 31, 2023, respectively 0 0
Common stock, $0.0001 par value; 24,000,000 shares authorized at June 30, 2023 and March 31, 2023, respectively, 5,141,596 and 4,933,550 shares issued and outstanding at June 30, 2023 and March 31, 2023, respectively (Note 7) 5 5
Additional paid-in capital 201,076 200,904
Accumulated deficit (190,932) (189,514)
Accumulated other comprehensive loss (2,907) (3,418)
Total stockholders’ equity 7,242 7,977
Total liabilities and stockholders’ equity $ 15,893 $ 16,231